News
More than three decades ago Sherman Williams was one of the state’s best high school football players gearing up for his senior season. Now, Williams is leading the ...
Should Arizona consider adding another corner to the room? Pickings are slim following the 2025 NFL Draft, but a small ...
Ouachita Baptist University has named 471 students to its President’s List for the Spring 2025 semester. To qualify for the ...
Seymour High School’s annual honor day program was held Friday. The event started with the Pledge of Allegiance led by Ismael Santiago Cruz, senior class president, followed by ...
While many pharma and biotech companies developing drugs to treat Alzheimer's disease are targeting amyloid beta plaque, Eli Lilly (NYSE:LLY) is looking at other targets as well. The drugmaker's ...
Eli Lilly & Co.’s stock soared 14% Thursday, to put it on track for its biggest one-day gain in about 25 years, after the drugmaker reported positive results from a late-stage trial of a GLP-1 ...
Hosted on MSN24d
Newsmakers 5/9/25: Key moments from Aaron Thomas trialSOUTH KINGSTOWN, R.I. (WPRI) — This week on Newsmakers: Tim White, Eli Sherman and the Boston Globe’s Amanda Milkovits are on location as the “naked fat test” trial of Aaron Thomas plays ...
Eli Lilly and Purdue University are changing how groundbreaking research can be funded as universities and labs across the country grapple with sudden federal funding cuts to vital research.
The "Tucker and Dale vs. Evil" director tells IndieWire about his new film, the socially-conscious slasher "Clown in a Cornfield." Adapted from Adam Cesare’s novel of the same name, the film ...
Eli K. Stoltzfus, 83, of 372 Red Well Road, New Holland, died Tuesday, May 6, 2025 at his residence. Born in Gordonville, he was the son of the late Stephen E. and Rebecca King Stoltzfus.
Eli Bohannan, a Walmart asset protection investigator, is running for Topeka City Council District 1. Bohannan's campaign priorities include addressing homelessness, infrastructure and education.
Being first to market with a drug can be crucial. Eli Lilly is proving that being second but better can also pay. Zepbound, the American firm’s weight-loss jab, was approved in its home country ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results